Financial statements Arsmedica
Balance sheet data of ARSMEDICA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 865 571,31 | 2 099 345,75 | 1 862 479,21 | 1 721 896,61 | 1 633 307,42 | 1 455 372,82 |
| A. Fixed assets | 458 088,77 | 1 849 650,50 | 1 822 406,40 | 1 644 558,77 | 1 480 550,35 | 1 298 169,34 |
| B. Current assets | 407 482,54 | 249 695,25 | 40 072,81 | 77 337,84 | 152 757,07 | 157 203,48 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 865 571,31 | 2 099 345,75 | 1 862 479,21 | 1 721 896,61 | 1 633 307,42 | 1 455 372,82 |
| A. Equity | 123 847,41 | 243 279,21 | 53 330,14 | 9 705,94 | -42 156,15 | 48 529,33 |
| B. Liabilities and provisions for liabilities | 741 723,90 | 1 856 066,54 | 1 809 149,07 | 1 712 190,67 | 1 675 463,57 | 1 406 843,49 |
| I. Long-term liabilities | 600 000,00 | 1 229 195,26 | 1 105 736,54 | 1 002 724,10 | 866 610,86 | 726 051,30 |
| II. Short-term liabilities | 141 723,90 | 626 871,28 | 703 412,53 | 709 466,57 | 808 852,71 | 680 792,19 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.